Sleep apnea is an important risk factor for atrial fibrillation. It is also associated with hypertension, coronary artery disease, heart failure, stroke, diabetes, and insulin resistance, all of which are risk factors for, or results of, atrial fibrillation. Now a new study has just reported that men between the ages of 40 and 70 who …
Read More
In Part 2 of StopAfib.org's video interview with Dr. Michael Argenziano, of NY-Presbyterian/Columbia University Medical Center, he discusses a trial that they are participating in that involves implanting a heart rhythm monitor after an atrial fibrillation procedure to see what a patient's rhythm looks like five, ten, and even twenty years later. Video Interview with …
Read More
In Part 1 of StopAfib.org's video interview with Dr. Michael Argenziano, he discusses the atrial fibrillation surgery done at NY-Presbyterian/Columbia University Medical Center. He covers the kind of surgery that he prefers for those with recent-onset paroxysmal atrial fibrillation as well as for those with one or more failed catheter ablations, for whom he favors …
Read More
We hear from so many afib patients every day about the trials, tribulations, and fears regarding being on amiodarone, or their refusal to take it. Since the FDA approved Multaq® (dronedarone) recently, the most frequent question I've fielded has been "When will Multaq® be available?" That happened this week, and the excitement they have shared …
Read More
Medtronic has completed 12 months of follow up in their U.S.-based STOP-AF clinical trial (Sustained Treatment of Paroxysmal Atrial Fibrillation) for treatment of paroxysmal atrial fibrillation. This trial evaluated their cryoballoon catheter, the Arctic Front® CryoAblation Catheter System, which is already approved for use in Europe, Australia and Hong Kong. Learn more: Medtronic Clinical Trial …
Read More
In this video interview, Dr. David Wilber talks about atrial fibrillation catheter ablation clinical trials and afib treatment as reported on at the Heart Rhythm Society 2009 annual meeting. Video Interview with Dr. David Wilber at Heart Rhythm 2009
Read More
In this video interview, Dr. Steven Hao talks about the atrial fibrillation ablation trial, using the THERMOCOOL® catheter, which was presented at the Heart Rhythm Society 2009 annual meeting. He also discussed upcoming catheter ablation studies for afib and improvements in technology to customize atrial fibrillation treatment to a patient's individual anatomy. Video Interview with …
Read More
BREAKING NEWS Multaq(R), the much anticipated replacement for amiodarone, just received FDA approval. Read the press release: FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter
Read More
Through the American Recovery and Reinvestment Act of 2009, the US federal government has allocated $1.1 billion for research into the comparative effectiveness of different medical treatments. New reports just out prioritize atrial fibrillation treatment on this comparative effectiveness research agenda. Comparative effectiveness research has the potential to improve atrial fibrillation patient treatment and save …
Read More
UPDATED 6-30-09: Study is now complete. An afib research study is looking for afib patients who are near San Francisco, Cincinnati, or New Jersey/New York and who have taken certain anti-arrhythmic medications (Flecainide, Rythmol, Propafenone, and similar). They are offering an honorarium for your time. Find out if you qualify at: Atrial Fibrillation Research Study …
Read More